[eBook] Therapeutic proteins: bioprocessing methods for mAb generation
Supplied by Eppendorf on Wednesday, 20 November, 2024
Antibodies have long been vital in research and diagnostics, but their lab utility was limited by their polyclonal nature. To stay competitive, production must become more efficient, cost-effective, and higher in quality.
Download this eBook to learn about:
·key methods for mAb validation and development
·the potential of P. pastoris as a next-gen mAb production platform
·strategies for ensuring reliable, reproducible mAb research and drug development.
Related White Papers
Leveraging Adeno-Associated Viruses (AAVs) in therapeutic approaches for monogenic neurological diseases
Learn about key strategies and innovations in this...
Continuous environmental monitoring — compliance and best practice tips
Automated environmental monitoring systems are now a critical element in many laboratory...
Monitoring with mean kinetic temperature in GxP environments
Regulatory bodies in drug manufacturing and distribution have long been working together to...
